Open AccessPamidronate as first-line treatment of hypercalcemia in neonatal subcutaneous fat necrosis: A case series
Author(s) -
Alexander Chesover,
Jennifer Harrington,
Farid H. Mahmud
Publication year - 2019
Publication title -
paediatrics and child health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.55
H-Index - 43
eISSN - 1918-1485
pISSN - 1205-7088
DOI - 10.1093/pch/pxz141
Subject(s) - nephrocalcinosis , medicine , furosemide , asymptomatic , gastroenterology , bisphosphonate , endocrinology , urology , osteoporosis , kidney
Subcutaneous fat necrosis (SCFN) can be complicated by severe hypercalcemia, which is frequently asymptomatic. Nephrocalcinosis is associated with hypercalcemia and, in other clinical settings, has been linked to furosemide and glucocorticoid use. First-line bisphosphonate therapy treating hypercalcemia in neonatal SCFN is not well described.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom